Fund Universe

← Fund Universe

☆Remedium Capital Partners, LLC

CIK 0002104501 · holdings for 2026Q2 (change vs 2026Q1) · in signal universe
Quality Q
0.877
AUM ($M)
452
Positions
6
Turnover
0.10
Top-10 wt
100%
Herfindahl
0.242
History (qtrs)
3
Excess Return
-52.2%

AI Eval Run AI Eval

No AI Eval requested yet for this fund.
Quarter
Activity this period
Security type

Holdings · 7 positions · portfolio value $452M

TickerNameActivitySecurity Type WeightΔ Weight Value ($M)SharesΔ Shares Qtrs HeldExcess Return
☆ORKA funds › Oruka Therapeutics Inc TRIM Common Stock 33.0% +4.0% 149.0 1,565,661 -323,454 2 —
☆SYRE funds › Spyre Therapeutics Inc TRIM Common Stock 28.8% -1.3% 130.0 1,464,169 -443,158 2 —
☆APGE funds › Apogee Therapeutics Inc ADD — 17.2% +1.9% 77.9 586,691 +3,100 2 —
☆DMRA funds › Damora Therapeutics Inc HOLD — 11.8% -4.8% 53.2 2,045,473 +0 2 —
☆JBIO funds › Jade Biosciences Inc HOLD Common Stock 7.8% +0.8% 35.1 1,577,750 +0 2 —
☆CBIO funds › Crescent Biopharma Inc NEW — 1.4% +1.4% 6.5 361,250 +361,250 1 -52.2%
☆CUSIP:38000Q201 funds › Crescent Biopharma Inc EXIT — 0.0% -2.1% 0.0 0 -361,250 0 —

Point-in-time history

Each row is this fund as of that period, not as of today — what the scoring for that quarter actually saw.
PeriodAUM ($M)Positions TurnoverTop-10 wtHerfindahl Quality Q Skill Universe
2026Q2 452 6 0.08 100% 0.242 0.890 — in
2026Q1 320 6 0.18 100% 0.231 0.742 — entered
2025Q4 170 6 0.00 100% 0.243 0.000 — out
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status